Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C.

J Affect Disord. 2019 Jan 15;243:516-524. doi: 10.1016/j.jad.2018.09.037. Epub 2018 Sep 17.

PMID:
30286416
2.

Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction.

Cassano P, Dording C, Thomas G, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV.

Lasers Surg Med. 2018 Sep 17. doi: 10.1002/lsm.23011. [Epub ahead of print]

PMID:
30221776
3.

Prevalence of Hepatitis B virus and Hepatitis D virus Coinfection in Western Burkina Faso and molecular characterization of the detected virus strains.

Sanou AM, Benkirane K, Tinto B, Cissé A, Sagna T, Ilboudo AK, Dording C, Tarnagda Z, Muller CP, Hübschen JM.

Int J Infect Dis. 2018 May;70:15-19. doi: 10.1016/j.ijid.2018.02.004. Epub 2018 Feb 9.

4.

Factors Associated With New-Onset Depression Following Ischemic Stroke: The Women's Health Initiative.

Salinas J, Ray RM, Nassir R, Lakshminarayan K, Dording C, Smoller J, Wassertheil-Smoller S, Rosand J, Dunn EC.

J Am Heart Assoc. 2017 Feb 1;6(2). pii: e003828. doi: 10.1161/JAHA.116.003828.

5.

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M.

Aust N Z J Psychiatry. 2017 Jan;51(1):55-64. doi: 10.1177/0004867416631828.

PMID:
26893373
6.

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study.

Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD.

J Psychiatr Res. 2015 Nov;70:98-105. doi: 10.1016/j.jpsychires.2015.08.016. Epub 2015 Aug 29.

PMID:
26424428
7.

College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity.

Nyer M, Mischoulon D, Alpert JE, Holt DJ, Brill CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A.

Ann Clin Psychiatry. 2015 May;27(2):100-8.

8.

A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women.

Dording CM, Schettler PJ, Dalton ED, Parkin SR, Walker RS, Fehling KB, Fava M, Mischoulon D.

Evid Based Complement Alternat Med. 2015;2015:949036. doi: 10.1155/2015/949036. Epub 2015 Apr 14.

9.

Massachusetts General Hospital SAFER criteria for clinical trials and research.

Desseilles M, Witte J, Chang TE, Iovieno N, Dording C, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D.

Harv Rev Psychiatry. 2013 Sep-Oct;21(5):269-74. doi: 10.1097/HRP.0b013e3182a75cc7. No abstract available.

10.

A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.

Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M.

J Clin Psychiatry. 2014 Apr;75(4):370-6. doi: 10.4088/JCP.13m08591.

11.

The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.

Dording C, Cassiello C, King F 4th, Pencina M, Fava M, Mischoulon D.

Int Clin Psychopharmacol. 2013 Sep;28(5):238-44. doi: 10.1097/YIC.0b013e32836220df.

PMID:
23764521
12.

The effect of sildenafil on quality of life.

Dording CM, LaRocca RA, Hails KA, Vitolo OV, Wisniewski SR, Balasubramani GK, Trivedi M, Fava M, Mischoulon D.

Ann Clin Psychiatry. 2013 Feb;25(1):3-10.

PMID:
23376864
13.

Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.

Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M.

CNS Spectr. 2012 Jun;17(2):76-86. doi: 10.1017/S1092852912000430.

14.

Comparison of academic and nonacademic sites in multi-center clinical trials.

Dording CM, Dalton ED, Pencina MJ, Fava M, Mischoulon D.

J Clin Psychopharmacol. 2012 Feb;32(1):65-8. doi: 10.1097/JCP.0b013e31823f3b47.

PMID:
22198440
15.

Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire.

Desseilles M, Witte J, Chang TE, Iovieno N, Dording CM, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D.

J Clin Psychiatry. 2011 Aug;72(8):1152-4. doi: 10.4088/JCP.11ac07225. No abstract available.

16.

Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies.

Fava M, Dording CM, Baker RA, Mankoski R, Tran QV, Forbes RA, Eudicone JM, Owen R, Berman RM.

Prim Care Companion CNS Disord. 2011;13(1). pii: PCC.10m00994. doi: 10.4088/PCC.10m00994gre.

17.

The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.

Rapaport MH, Nierenberg AA, Howland R, Dording C, Schettler PJ, Mischoulon D.

J Psychiatr Res. 2011 Jul;45(7):931-41. doi: 10.1016/j.jpsychires.2011.05.001. Epub 2011 May 31.

18.

SAMe and sexual functioning.

Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI.

Eur Psychiatry. 2012 Aug;27(6):451-4. doi: 10.1016/j.eurpsy.2011.01.003. Epub 2011 Mar 12.

PMID:
21398094
19.

Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome.

Dording CM, Mischoulon D, Goodness TM, Baer L, Clain A, Stewart JW, Matthews JD, McGrath PJ, Nierenberg AA, Fava M, Papakostas GI.

CNS Spectr. 2010 Aug;15(8):515-21.

PMID:
20703198
20.

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.

Farabaugh AH, Bitran S, Witte J, Alpert J, Chuzi S, Clain AJ, Baer L, Fava M, McGrath PJ, Dording C, Mischoulon D, Papakostas GI.

Int Clin Psychopharmacol. 2010 Jul;25(4):214-7. doi: 10.1097/YIC.0b013e328339fbbd.

21.

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.

Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M.

J Clin Psychiatry. 2009 Dec;70(12):1636-44. doi: 10.4088/JCP.08m04603. Epub 2009 Aug 25.

22.

The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.

Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D.

Nord J Psychiatry. 2009;63(5):420-5. doi: 10.1080/08039480903015396.

PMID:
19521922
23.

An open study of aripiprazole and escitalopram for psychotic major depressive disorder.

Matthews JD, Siefert C, Dording C, Denninger JW, Park L, van Nieuwenhuizen AO, Sklarsky K, Hilliker S, Homberger C, Rooney K, Fava M.

J Clin Psychopharmacol. 2009 Feb;29(1):73-6. doi: 10.1097/JCP.0b013e318193dfb4.

PMID:
19142112
24.

A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.

Dording CM, Fisher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D.

CNS Neurosci Ther. 2008 Fall;14(3):182-91. doi: 10.1111/j.1755-5949.2008.00052.x.

PMID:
18801111
25.

Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.

Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M.

Psychiatry Res. 2008 Oct 30;161(1):116-20. doi: 10.1016/j.psychres.2008.02.011. Epub 2008 Aug 27.

PMID:
18755514
26.

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.

Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M.

Eur Neuropsychopharmacol. 2008 Sep;18(9):639-45. doi: 10.1016/j.euroneuro.2008.04.011. Epub 2008 Jun 6.

PMID:
18539007
27.

The impact of medical comorbidity on acute treatment in major depressive disorder.

Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M.

Am J Psychiatry. 2003 Dec;160(12):2122-7.

PMID:
14638581
28.

The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.

Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE, Fava M.

Ann Clin Psychiatry. 2002 Sep;14(3):143-7.

PMID:
12585563
29.

An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.

Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M.

J Clin Psychiatry. 2002 Dec;63(12):1164-70.

PMID:
12523877
30.

A survey of prescribing practices in the treatment of depression.

Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):177-87.

PMID:
11853110
31.

Principles and narrative in forensic psychiatry: toward a robust view of professional role.

Candilis PJ, Martinez R, Dording C.

J Am Acad Psychiatry Law. 2001;29(2):167-73.

PMID:
11471782
32.

Antidepressant augmentation and combinations.

Dording CM.

Psychiatr Clin North Am. 2000 Dec;23(4):743-55. Review.

PMID:
11147245

Supplemental Content

Loading ...
Support Center